Publications:167
- Home
- Profiles
Augusto Villanueva Rodriguez, MD, PhD
- About Me
- Clinical Focus
- Video
- Education & Certifications
- Awards
- Locations
- Publications
- Patient Experience RatingPatient Experience Star Ratings and Comments
- Industry Relationships
About Me
Language
Position
Research Topics
Cancer, Liver
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
About Me
Language
Position
Research Topics
Cancer, Liver
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
Clinical Focus
- Abnormal Liver Enzymes
- Alcoholic Liver Disease
- Autoimmune Liver Disease
- Bile Duct Diseases
- Cholecystitis
- Chronic Liver Disease
- Cirrhosis
- Fatty Liver Disease
- Gallbladder Polyp
Show More
- Abnormal Liver Enzymes
- Alcoholic Liver Disease
- Autoimmune Liver Disease
- Bile Duct Diseases
- Cholecystitis
- Chronic Liver Disease
- Cirrhosis
- Fatty Liver Disease
- Gallbladder Polyp
- Gallstones
- Gilbert's Syndrome
- HIV-related liver disease
- Hemangioma
- Hemochromatosis
- Hepatic Adenoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatocellular Carcinoma
- Jaundice
- Liver Abscess
- Liver Cancer
- Liver Mass
- Metabolic Dysfunction Associated Steatohepatitis (MASH)
- Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
- Nonalcoholic Fatty Liver Disease
- Nonalcoholic steatohepatitis
- Steatotic Liver Disease
- Toxic Hepatitis
- Wilson's Disease
Video
Education
MD, University of Santiago de Compostela
Residence, Gastroenterology & Hepatology, University Hospital of Santiago de Compostela
PhD, Biomedical Research, University of Santiago de Compostela
MS, Research in Liver Diseases, University of Barcelona
Awards
2018
Junior Faculty Award
GE Liver Gene Expression
2015
Alan Hofmann Clinical and Translational Award in Liver Diseases
American Association for the Study of Liver Diseases Foundation
2013
Rising Star Gastroenterologist, United European Gastroenterology
2008
Sheila Sherlock Fellowship, European Association for the Study of the Liver
2007
Juan Rodes Award, Asociacion Española para el Estudio del Higado
2005
Pedro Barrie de la Maza Fellow, Foundation Banco Pastor
2000
National Award for Excellence in Academic Performance, Ministry of Edication (Goverment of Spain)
Locations
Publications
Selected Publications
- Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis. Kornelius Schulze, Tim Daniel Rose, Lorenz Adlung, Manuela Peschka, Francesca Pagani, Joao Gorgulho, Thorben W. Fründt, Ismail Labgaa, Philipp K. Haber, Carolin Zimpel, Darko Castven, Arndt Weinmann, Teresa Garzia-Lezana, Moritz Waldmann, Thomas Renné, Hannah Voß, Manuela Moritz, Dorian Orlikowski, Hartmut Schlüter, Jan Baumbach, Myron Schwartz, Ansgar W. Lohse, Samuel Huber, Bruno Sangro, Rocio I.R. Macias, Laura Izquierdo-Sanchez, Jesus M. Banales, Henning Wege, Jens U. Marquardt, Augusto Villanueva, Josch Konstantin Pauling, Johann von Felden. JHEP Reports
- Current and emerging strategies for the prevention of hepatocellular carcinoma. Yee Hui Yeo, Manal Abdelmalek, Seema Khan, Cynthia A. Moylan, Luz Rodriquez, Augusto Villanueva, Ju Dong Yang. Nature Reviews Gastroenterology and Hepatology
- Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data. Wee Han Ng, Yee Hui Yeo, Hyunseok Kim, Ekihiro Seki, Jonathan Rees, Kevin Sheng Kai Ma, Cynthia A. Moylan, Luz María Rodriquez, Manal Abdelmalek, Augusto Villanueva, Mazen Noureddin, Ju Dong Yang. Hepatology
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Villanueva Rodriguez during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Caris
- Outcomes insights
- Espervita
- NGM Pharmaceuticals
- Eisai, Inc.
- Pioneering Medicine
- Medpace, Inc.
- First Word
- Elevar Therapeutics
- Society of Interventional Oncology
- Genentech, Inc.
- Astrazeneca
- FUJIFILM PHARMACEUTICALS U.S.A., INC
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Espervita
- Atzeyo Biosensors
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Villanueva Rodriguez during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Caris
- Outcomes insights
- Espervita
- NGM Pharmaceuticals
- Eisai, Inc.
- Pioneering Medicine
- Medpace, Inc.
- First Word
- Elevar Therapeutics
- Society of Interventional Oncology
- Genentech, Inc.
- Astrazeneca
- FUJIFILM PHARMACEUTICALS U.S.A., INC
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Espervita
- Atzeyo Biosensors
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.